WS #14242
Holding: newest synthesis is 75d 14h old
Argenx shares jumped after positive Phase 3 results for Vyvgart in autoimmune myositis, a high-significance biotech catalyst.
Argenx positive Phase 3 results
Argenx shares jumped after positive Phase 3 results for Vyvgart in autoimmune myositis, a high-significance biotech catalyst.